Heart Surgery

Latest Issue of OR Manager
October 2024
Home Surgery/Specialties > Heart Surgery

First assistants bring expertise and efficiency to the OR table--Part 2

First assistants (FAs) can play an important role in achieving optimal outcomes and higher surgical case volumes. Part 1 of this two-part series discussed types, education, and certification of FAs (OR Manager, May 2021, pp 1, 15-18). Part 2 answers questions related to risk management and oversight, and discusses possible…

Read More

By: Cynthia Saver, MS, RN
May 19, 2021
Share

Trends in surgical caseloads during COVID-19

Editor's Note Urban hospitals bounced back faster than rural hospitals from surgical caseload decreases caused by the COVID-19 pandemic, finds a new study released May 13 by Caresyntax, a Boston-based developer of surgical intelligence and automation technologies. The study, “The State of Surgery: An Analysis of Surgical Trends During the…

Read More

By: Judy Mathias
May 17, 2021
Share

FDA: Class I recall of Medtronic’s Extracorporeal Blood Pumping Console

Editor's Note The Food and Drug Administration (FDA), on April 20, identified the recall of Medtronic’s Bio-Console 560 Extracorporeal Blood Pumping Console as Class I, the most serious. The Console is used during heart surgery to pump and return blood to a patient during cardiopulmonary bypass. The recall was initiated…

Read More

By: Judy Mathias
April 22, 2021
Share

FDA issues Class I recall of certain Medtronic ICDs, CRT-Ds

Editor's Note The Food and Drug Administration (FDA), on April 12, identified the recall of Medtronic’s Evera, Viva, Brava, Claria, Amplia, Compia, and Visia implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) as Class I, the most serious. The recall was initiated because of an unexpected and rapid…

Read More

By: Judy Mathias
April 19, 2021
Share

Sponsored Message

FDA: Class I recall of Medtronic’s Valiant Navion Thoracic Stent Graft System

Editor's Note The Food & Drug Administration (FDA), on April 9, identified the recall of Medtronic’s Valiant Navion Thoracic Stent Graft System as Class I, the most serious. The recall was initiated because of the risk of stent fractures and endoleak concerns. The system is used to repair lesions of…

Read More

By: Judy Mathias
April 12, 2021
Share

FDA: Class I recall of Medtronic Affinity Pixie Oxygenator and Cardiotomy/Venous Reservoir with Balance Biosurface

Editor's Note The Food and Drug Administration (FDA), on March 24, identified the recall by Medtronic of its Affinity Pixie Oxygenator and Cardiotomy/Venous Reservoir with Balance Biosurface as Class I, the most serious. The recall was issued because of potentially elevated levels of harmful bacterial endotoxins. Use of a device…

Read More

By: Judy Mathias
March 25, 2021
Share

Sponsored Message

FDA: Class I recall of Medtronic's HVAD Pump Implant Kits

Editor's Note The Food and Drug Administration (FDA) on March 1 identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) Pump Implant Kits as Class I, the most serious. The kit is part of the HeartWare HVAD System, which is used to help the heart pump blood…

Read More

By: Judy Mathias
March 3, 2021
Share

‘COVID effect’ leads to fewer cardiac surgeries, more deaths

Editor's Note The COVID-19 pandemic has resulted in a substantial decline in cardiac surgery volume and an unexplained increase in deaths after coronary artery bypass grafting (CABG), finds this study presented January 30 at the Annual Meeting of the Society of Thoracic Surgeons (STS). Researchers from the University of California,…

Read More

By: Judy Mathias
February 8, 2021
Share

American Heart Association warns of cardiovascular risks of marijuana use

Editor's Note In a Scientific Statement, the American Heart Association (AHA) says marijuana use has no cardiovascular benefits and that it has been linked to an increased risk of heart attacks, atrial fibrillation, and heart failure. Though a full understanding of how marijuana use affects the heart and blood vessels…

Read More

By: Judy Mathias
August 10, 2020
Share

ACS opposes proposed Medicare physician fee schedule

Editor's Note The American College of Surgeons (ACS) on August 4 announced that it is strongly opposed to the Centers for Medicare & Medicaid Services (CMS) Physician Fee Schedule proposed rule for CY 2021. In the fee schedule, which is set to take place January 1, 2021, Medicare payments will…

Read More

By: Judy Mathias
August 6, 2020
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat